Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 42Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Meningeal Carcinomatosis 20Brain Neoplasms 18Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 8Neoplasm Metastasis 3Lymphoma 3Glioma 3Central Nervous System Neoplasms 3Neoplasms 2Medulloblastoma 2Lung Diseases 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Thoracic Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

fludarabine phosphate 1anlotinib 1aflutinib 1Temozolomide 1Specimen Handling 1Radiotherapy 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Fluorodeoxyglucose F18 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cisplatin 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Pemetrexed × CNS × Clear all
NCT01578668 2015-01-26

Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Guangzhou Medical University

Phase 2 Completed
69 enrolled
CNSThoracic

Adenocarcinoma of Lung, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡